Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data

BMC Medical Research Methodology

Volumn 7, Issue , 2007, Pages

  Friedrich, Jan O ^a,b   Adhikari, Neill K J ^a,c   Beyene, Joseph ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CALCULATION; CONFIDENCE INTERVAL; OUTCOME ASSESSMENT; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; HUMAN; META ANALYSIS (TOPIC); PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS;

HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC;

EID: 33846511123     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-7-5     Document Type: Article

References (17)

1. Measuring inconsistency in meta-analysis. JPT Higgins SG Thompson JJ Deeks DG Altman, BMJ 2003 327 557 560 12958120 10.1136/bmj.327.7414.557
2. Meta-analysis in clinical trials. R DerSimonian N Laird, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833
3. The Cochrane Collaboration, Cochrane Handbook for Systematic Reviews of Interventions Oxford: The Cochrane Collaboration 2005 http://www.cochrane.org/ resources/handbook/
4. The Cochrane Collaboration, RevMan 4.2 User Guide Oxford: The Cochrane Collaboration 2005 http://www.cc-ims.net/RevMan/documentation.htm
5. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. MJ Sweeting AJ Sutton PC Lambert, Stat Med 2004 23 1351 1375 10.1002/sim.1761 15116347
6. A general parametric approach to the meta-analysis of randomized clinical trials. A Whitehead J Whitehead, Stat Med 1991 10 1665 1677 1792461
7. Antibiotics for sore throat to prevent rheumatic fever: yes or no? How the Cochrane Library can help. A Ohlsson K Clark, CMAJ 2004 171 721 723 15451830
8. An assessment of the use of the continuity correction for sparse data in meta-analysis. SS Sankey LA Weissfeld MJ Fine W Kapoor, Communications in Statistics-Simulation and Computation 1996 25 1031 1056
9. The continuity correction. DR Cox, Biometrika 1970 57 217 219 10.1093/biomet/57.1.217
10. Antifungal prophylaxis for severely neutropenic chemotherapy receipients. A meta-analysis of randomized-controlled clinical trials. EJ Bow M Laverdiere N Lussier C Rotstein MS Cheang S Ioannou, Cancer 2002 94 3230 3246 10.1002/cncr.10610 12115356
11. Stress ulcer prophylaxis in the critically ill: a meta-analysis. DJ Cook LG Witt RJ Cook GH Guyatt, Am J Med 1991 91 519 527 10.1016/0002-9343(91)90189-5 1835294
12. Meta-analysis: principles and procedures. M Egger G Davey Smith AN Phillips, BMJ 1997 315 1533 1537 9432252
13. Meta-Analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. JO Friedrich N Adhikari MS Herridge J Beyene, Ann Intern Med 2005 142 510 524 15809463
14. Antibiotics for sore throat. CB Del Mar PP Glasziou AB Spinks, Cochrane Database Syst Rev 2004 2 CD000023 15106140
15. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. HHG Handoll MJ Farrar J McBirnie G Tytherleigh-Strong KA Awal AA Milne WJ Gillespie, Cochrane Database Syst Rev 2002 4 CD000305 12519540
16. Weighting bias in meta-analysis of binary outcomes. JL Tang, J Clin Epidemiol 2000 53 11 1130 6 10.1016/S0895-4356(00)00237-7 11106886
17. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. MJ Bradburn JJ Deeks JAW Berlin AR Localio, Statist Med 2007 26 53 77 10.1002/sim.2528